Baby Safety / Compounds / Nonanal

Is Nonanal safe for babies and kids?

Low risk for kids

(Babies-specific data is limited; this page draws from human adult context.) Nonanal poses low risk to adults under normal use conditions.

What is nonanal?

Also known as: 1-Nonanal, Pelargonaldehyde, Nonanaldehyde, Nonyl aldehyde.

CAS number
124-19-6
Molecular formula
C9H18O
Molecular weight
142.24 g/mol
SMILES
CCCCCCCCC=O
PubChem CID
31289

Risk for babies

Low risk

Nonanal poses low risk to adults under normal use conditions.

Regulatory consensus

2 regulatory and scientific bodies have classified Nonanal. The classifications differ — that's the data.

AgencyYearClassificationNotes
IFRA——Approved for use in fragrance compounds
EU——Complies with EU cosmetics regulations

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter nonanal

  • Perfume
  • Personal Care

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Nonanal:

  • Essential oil-free fragrance formulations
    Trade-offs: Allows scent without specific natural allergens; synthetic molecules can be individually safety-tested; some synthetics have their own sensitization profiles; cost comparable to natural blends.
    Relative cost: Lower (ingredient elimination)
  • Naturally-derived isolates with established safety profiles (e.g., linalool, limonene at controlled concentrations)
    Trade-offs: Removes 95-99% of dissolved contaminants including metals, PFAS, nitrates; wastes 2-4 gallons per gallon produced (improving with newer systems); removes beneficial minerals; $0.05-0.25/gallon; requires pre-treatment for longevity.
    Relative cost: 2-5× conventional
  • Fragrance-free product alternatives
    Trade-offs: Eliminates allergen risk entirely; consumer acceptance varies (some associate scent with cleanliness/efficacy); growing market segment; regulatory advantage in EU (no IFRA compliance needed).
    Relative cost: Lower (ingredient elimination)
  • Encapsulated fragrance technologies (reduced skin contact)
    Trade-offs: Reduces dermal contact by 60-90% via polymer shell release mechanism; higher formulation cost; may alter scent perception (delayed release); shell material itself requires safety assessment.
    Relative cost: 1.2-2×

Frequently asked questions

No FAQ entries generated.

See Nonanal in the baby app

Look up products containing nonanal, compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. ATSDR Toxicological Profile — CAS 124-19-6 — reference

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →